160 related articles for article (PubMed ID: 7916910)
1. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
[TBL] [Abstract][Full Text] [Related]
2. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
7. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
Hallberg A; Juhlin C; Berne C; Kämpe O; Karlsson FA
J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
9. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
[TBL] [Abstract][Full Text] [Related]
10. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
DeAizpurua HJ; Honeyman MC; Harrison LC
J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
[TBL] [Abstract][Full Text] [Related]
11. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
[TBL] [Abstract][Full Text] [Related]
12. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.
Genovese S; Bonifacio E; McNally JM; Dean BM; Wagner R; Bosi E; Gale EA; Bottazzo GF
Diabetologia; 1992 Apr; 35(4):385-8. PubMed ID: 1516768
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.
Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA
Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus.
Rowley MJ; Mackay IR; Chen QY; Knowles WJ; Zimmet PZ
Diabetes; 1992 Apr; 41(4):548-51. PubMed ID: 1607079
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes.
Kohnert KD; Hehmke B; Keilacker H; Ziegler M; Emmrich F; Laube F; Michaelis D
Int J Clin Lab Res; 1996; 26(1):55-9. PubMed ID: 8739857
[TBL] [Abstract][Full Text] [Related]
17. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).
Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T
Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172
[TBL] [Abstract][Full Text] [Related]
18. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
20. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
